Search Close Search
Page Menu


Haddadi N-S, Mande P, Brodeur TY, Hao K, Ryan GE, Moses S, Subramanian S, Picari X, Afshari K, Marshak-Rothstein A and Richmond JM (2022) Th2 to Th1 Transition Is Required for Induction of Skin Lesions in an Inducible and Recurrent Murine Model of Cutaneous Lupus–Like Inflammation. Front. Immunol. 13:883375. 

April M. JorgeTaotao LaoRachel KimSamantha LicciardiJoseph El KhouryAndrew D. LusterTerry K. MeansZaida G. Ramirez-Ortiz; SCARF1-Induced Efferocytosis Plays an Immunomodulatory Role in Humans, and Autoantibodies Targeting SCARF1 Are Produced in Patients with Systemic Lupus Erythematosus. J Immunol 15 February 2022; 208 (4): 955–967.

Lubov JE, Jamison AS, Baltich Nelson B, Amudzi AA, Haas KN and Richmond JM (2022) Medicinal Plant Extracts and Natural Compounds for the Treatment of Cutaneous Lupus Erythematosus: A Systematic Review. Front. Pharmacol. 13:802624.

Amudzi AA, Piedra-Mora C, Ma DJ, Wong NB, David CN, Robinson NA, Almela RM and Richmond JM (2022) Using Gene Expression Analysis to Understand Complex Autoimmune Skin Disease Patients: A Series of Four Canine Cutaneous Lupus Erythematosus Cases. Front. Vet. Sci. 9:778934.

Colton J. Garelli, Neil B. Wong, Cesar Piedra-Mora, Linda M. Wrijil, Gina Scarglia, Clement N. David, Ramón M. Almela, Nicholas A. Robinson, Jillian M. Richmond, Shared inflammatory and skin-specific gene signatures reveal common drivers of discoid lupus erythematosus in canines, humans and mice, Current Research in Immunology,
Volume 2, 2021, Pages 41-51,ISSN 2590-2555.

Pellerin A, Yasuda K, Cohen-Bucay A, et al. Monoallelic IRF5 deficiency in B cells prevents murine lupus. JCI Insight. 2021;6(15):e141395.
Published 2021 Aug 9. 

Motwani M, McGowan J, Antonovitch J, et al. cGAS-STING Pathway Does Not Promote Autoimmunity in Murine Models of SLE. Front Immunol. 2021;12:605930. Published 2021 Mar 29. 

Garelli CJ, NB Wong, C Piedra-Mora, LM Wrijil, G Scarglia, CN David, RM Almela, NA Robinson & JM Richmond. “Shared inflammatory and skin-specific gene signatures reveal common drivers of discoid lupus erythematosus in canines, humans and mice.” Curr Res Immunol. 2021; (2) 41-51. 

Garelli, CJ, MA Refat, PP Nanaware, ZG Ramirez-Ortiz, M Rashighi & JM Richmond. “Current insights in Cutaneous Lupus Erythematosus immunopathogenesis.” Front Immunol. 2020 Jul 2;11:1353.

Gkrouzman E, Willis R, Andrade D, Tektonidou MG, Pengo V, Ruiz-Irastorza G, Belmont HM, Fortin PR, Gerosa M, Signorelli F, Atsumi T, Branch DW, Nalli C, Rodriguez-Almaraz E, Petri MA, Cervera R, Knight JS, Efthymiou M, Cohen H, Bertolaccini ML, Erkan D, Roubey R; APS ACTION. Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An APS ACTION Study. Lab Invest. 2023 Apr 10:100147. doi: 10.1016/j.labinv.2023.100147. Online ahead of print. PMID: 37044248

Bass AR, Chakravarty E, Akl EA, Bingham CO, Calabrese L, Cappelli LC, Johnson SR, Imundo LF, Winthrop KL, Arasaratnam RJ, Baden LR, Berard R, Bridges SL Jr, Cheah JTL, Curtis JR, Ferguson PJ, Hakkarinen I, Onel KB, Schultz G, Sivaraman V, Smith BJ, Sparks JA, Vogel TP, Williams EA, Calabrese C, Cunha JS, Fontanarosa J, Gillispie-Taylor MC, Gkrouzman E, Iyer P, Lakin KS, Legge A, Lo MS, Lockwood MM, Sadun RE, Singh N, Sullivan N, Tam H, Turgunbaev M, Turner AS, Reston J. 2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases. Arthritis Care Res (Hoboken). 2023 Mar;75(3):449-464. doi: 10.1002/acr.25045. Epub 2023 Jan 4. PMID: 36597813.

Wang X*, Gkrouzman E*, Andrade DCO, Andreoli L, Barbhaiya M, Belmont HM, Branch DW, de Jesús GR, Efthymiou M, Ríos-Garcés R, Gerosa M, El Hasbani G, Knight J, Meroni PL, Pazzola G, Petri M, Rand J, Salmon J, Tektonidou M, Tincani A, Uthman IW, Zuily S, Zuo Y, Lockshin M, Cohen H, Erkan D; APS ACTION. COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION). Lupus. 2021 Dec;30(14):2276-2285. PMID 34915764
*Shared 1st authorship

Gkrouzman E, Peng M, Davis-Porada J, Kirou KA. Venous Thromboembolic Events in African American Lupus Patients are Less Likely Associated with Antiphospholipid Antibodies Compared to Caucasians. Arthritis Care Res (Hoboken). 2020 Nov 10. PMID 33171010

Gkrouzman E, Wu DD, Jethwa H, Abraham S. Telemedicine in Rheumatology at the Advent of the COVID-19 Pandemic. HSS J. 2020 Oct 6;16(Suppl 1):1-4. PMID 33041724

Gkrouzman E, Sevim E, Finik J, Andrade D, Pengo V, Sciascia S, Tektonidou MG, Ugarte A, Chighizola CB, Belmont HM, Lopez-Pedrera C, Ji L, Fortin P, Efthymiou M, de Jesus GR, Branch DW, Nalli C, Petri M, Rodriguez E, Cervera R, Knight JS, Atsumi T, Willis R, Bertolaccini ML, Cohen H, Rand J, Erkan D; APS ACTION. Antiphospholipid Antibody Profile Stability Over Time: Prospective Results from APS ACTION Clinical Database and Repository. J Rheumatol. 2020 Sep 1:jrheum.200513. doi: 10.3899/jrheum.200513. PMID 33259328

Gkrouzman E, Barbhaiya M, Erkan D, Lockshin MD. Reality check on antiphospholipid antibodies in COVID-19-associated coagulopathy. Arthritis Rheumatol. 2020 Jul 31. PMID 32901454

Gkrouzman E, Smith MH, Ghosh N, Laurence JC, Seshan SV, Vaughn JL, Levine AB, Bass AR, Erkan D. Recurrent Complement-Mediated Thrombotic Microangiopathy in a Patient with Systemic Lupus Erythematosus. HSS Jrnl 16, 507–514 (2020). PMID 33380989.

Caricchio R, Gallucci M, Dass C, et al. Response to: 'Correspondence on 'Preliminary predictive criteria for COVID-19 cytokine storm'' by Tampe et alAnn Rheum Dis. 2023;82(3):e72.

Moeller WJ, Potere N, Bonaventura A, Caricchio R, et al. Use of placebo in clinical trials in COVID-19 pandemic times: considerations on pros, cons, challenges and limitations. Minerva Med. 2022;113(6):1000-1007.

Potere N, Del Buono MG, Caricchio R, et al. Interleukin-1 and the NLRP3 inflammasome in COVID-19: Pathogenetic and therapeutic implications. EBioMedicine. 2022;85:104299.

Knight JS, Caricchio R, Casanova JL, et al. The intersection of COVID-19 and autoimmunity. J Clin Invest. 2021;131(24):e154886.

Cron RQ, Caricchio R, Chatham WW. Calming the cytokine storm in COVID-19. Nat Med. 2021;27(10):1674-1675.

Caricchio R, Abbate A, Gordeev I, et al. Effect of Canakinumab vs Placebo on Survival Without Invasive Mechanical Ventilation in Patients Hospitalized With Severe COVID-19: A Randomized Clinical Trial. JAMA. 2021;326(3):230-239.

Rali P, O'Corragain O, Oresanya L, Caricchio R,  et al. Incidence of venous thromboembolism in coronavirus disease 2019: An experience from a single large academic center [published correction appears in J Vasc Surg Venous Lymphat Disord. 2022 May;10(3):799]. J Vasc Surg Venous Lymphat Disord. 2021;9(3):585-591.e2.

Stearrett N, Dawson T, Rahnavard A, Caricchio R, et al. Expression of Human Endogenous Retroviruses in Systemic Lupus Erythematosus: Multiomic Integration With Gene Expression. Front Immunol. 2021;12:661437. Published 2021 Apr 27. 

Caricchio R, Gallucci M, Dass C, et al. Preliminary predictive criteria for COVID-19 cytokine storm. Ann Rheum Dis. 2021;80(1):88-95

Patel M, Dominguez E, Sacher D, Caricchio R, et al. Etoposide as Salvage Therapy for Cytokine Storm Due to Coronavirus Disease 2019. Chest. 2021;159(1):e7-e11.